XML 57 R45.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Disclosures - Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details) - Multi-Period Excess Earnings Method
Aug. 31, 2024
Probability of success for next development phase | KIO-104 | Minimum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
Probability of success for next development phase | KIO-104 | Maximum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.36
Probability of success for next development phase | KIO-301 | Minimum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.25
Probability of success for next development phase | KIO-301 | Maximum  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.45
Discount Rate | KIO-104  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.355
Discount Rate | KIO-301  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.355